Changes in intracellular calpastatin localization are mediated by reversible phosphorylation

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Calpastatin, an endogenous inhibitor of calpains, has been previously observed in an aggregated state near the nucleus in neuroblastoma LAN-5 cells.
• The regulation of calpastatin's localization and activity is crucial for cellular processes involving calpain activity.

Purpose of the Study:

• To investigate the phosphorylation state of aggregated calpastatin in neuroblastoma LAN-5 cells.
• To elucidate the role of intracellular calcium and cAMP in regulating calpastatin's distribution and phosphorylation.
• To understand the implications of these regulatory mechanisms on calpain inhibition.

Main Methods:

• Immunofluorescence microscopy to observe calpastatin localization.
• Biochemical assays to assess calpastatin phosphorylation status.
• Manipulation of intracellular calcium levels and treatment with cAMP and PMA to study dynamic changes.

Main Results:

• Aggregated calpastatin was found to be predominantly in a phosphorylated state.
• An increase in intracellular free calcium ([Ca2+]) induced calpastatin dephosphorylation via phosphoprotein phosphatase and its redistribution to a soluble inhibitor form.
• cAMP treatment reversed the distribution, favoring calpastatin aggregation, whereas PMA-induced phosphorylation did not have the same effect.

Conclusions:

• A reversible intracellular mechanism regulates the level of cytosolic calpastatin.
• This mechanism involves calcium-dependent dephosphorylation and cAMP-mediated re-aggregation.
• This dynamic regulation may allow calpain to escape calpastatin inhibition during its activation phases.